Immunogenicity and safety of two doses of the CoronaVac SARS-CoV-2 vaccine in SARS-CoV-2 seropositive and seronegative patients with autoimmune rheumatic diseases in Brazil: a subgroup analysis of a phase 4 prospective study.

ABSTRACT:

SUBMITTER: Aikawa NE 

PROVIDER: S-EPMC8641960 | biostudies-literature | 2022 Feb

REPOSITORIES: biostudies-literature